Sandoz-Irbesartan Product Recall (2021-05-27)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
Sandoz Irbesartan 150mg Tablet
| Lot or serial number | Companies | Brand name | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| KF8326 | - Recalling Firm
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| B. Sandoz Irbesartan 300mg Tablet | DIN 02328496 | Tablet | Irbesartan 300mg |
| KC7216 | - Recalling Firm
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
- Marketing Authorization Holder
- Sandoz Canada Inc
- 110 de Lauzon
- Boucherville
- J4B 1E6
- Quebec
- CANADA
| A. Sandoz Irbesartan 150mg Tablet | DIN 02328488 | Tablet | Irbesartan 150mg |
-
Sandoz Irbesartan 150mg Tablet
-
Sandoz Irbesartan 300mg Tablet
Presence of impurity 5-(4-(azidomethyl)-[1,1-biphenyl]-2-yl)-1H-tetrazole above the acceptable concentration limit in affected lots.